Skip to main content

Bellevue Group AG

Position in CYTK — Cytokinetics Inc

CIK 1674546 Zurich, V8

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,619,206
+$1,036,496 QoQ
Shares Held
19,007
+115.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#229
of 477 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. CYTK ranks #40 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CYTK

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,619,206 19,007
2026-03-31 $582,710 8,841
2025-12-31 $586,156 9,225
2025-09-30 $115,416 2,100
2025-06-30 $123,602 3,741
2025-03-31 $150,350 3,741
2024-12-31 $514,664 10,941
2024-09-30 $577,684 10,941
2024-06-30 $902,584 16,659
2024-03-31 $1,096,520 15,640
2023-12-31 $1,577,961 18,900
2023-09-30 $1,092,966 37,100
2023-06-30 $1,210,202 37,100
2023-03-31 $1,907,298 54,200
2022-12-31 $2,483,444 54,200
2022-09-30 $3,449,640 71,200
2022-06-30 $2,608,856 66,400
2022-03-31 $2,539,890 69,000